Skip to content

An Exploratory Study on the Microscopic Phenotypic Characteristics of Fengshi syndrome Precancerous Lesions of Gastric Cancer

An Exploratory Study on the Microscopic Phenotypic Characteristics of Fengshi syndrome Precancerous Lesions of Gastric Cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125511
Enrollment
Unknown
Registered
2026-05-27
Start date
2026-05-14
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric precancerous lesions

Interventions

Non-Fengshi precancerous lesions group:None
Fengshi precancerous lesions group:None

Sponsors

Guangzhou Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 70 years old, regardless of gender; 2. Suspected gastric precancerous lesions and willing to undergo gastroscopy and pathological examination to confirm the diagnosis; 3. Patients met the diagnostic criteria (chronic atrophic gastritis with intestinal metaplasia or dysplasia confirmed by pathology), and informed consent was obtained.

Exclusion criteria

Exclusion criteria: 1. Gastric cancer; 2. Combined with malignant tumors; 3. With other digestive diseases; 4. Complicated with serious heart, lung, liver, kidney and other important organ diseases; 5. Pregnant or lactating women; 6. Serious brain disease or mental disease that affects the patient's ability to report.

Design outcomes

Primary

MeasureTime frame
Clinical Symptom Scale Scoring;

Secondary

MeasureTime frame
Chinese Medicine Four Diagnostic Scale Scoring;

Countries

China

Contacts

Public ContactXiaobo Yang

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

yangxiaobomd@gzucm.edu.cn+86 138 2501 2636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026